ArticleJCO global oncology2026

Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.

Rubem Jose Peres Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.